The global Rinderpest Virus Vaccine market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Live Vaccine Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Rinderpest Virus Vaccine include Zoetis, Merck Animal Health, Hipra, Boehringer-Ingelheim, Ceva, Creative Biolabs, China Animal Husbandry Industry, Jinyu Bio-technology and TECON, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
The anti-rinderpest virus antibody produced after immunization with rinderpest virus vaccine can resist the attack of Peste des petits ruminants virus, and has a good immune protection effect. Injection of rinderpest virus vaccine is an important measure to control the outbreak and prevalence of the disease in beef cattle farms.
This report aims to provide a comprehensive presentation of the global market for Rinderpest Virus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rinderpest Virus Vaccine. This report contains market size and forecasts of Rinderpest Virus Vaccine in global, including the following market information:
- Global Rinderpest Virus Vaccine Market Revenue, 2019-2024, 2025-2030, ($ millions)
- Global Rinderpest Virus Vaccine Market Sales, 2019-2024, 2025-2030, (K Doses)
- Global top five Rinderpest Virus Vaccine companies in 2023 (%)
We surveyed the Rinderpest Virus Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rinderpest Virus Vaccine Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Doses)
Global Rinderpest Virus Vaccine Market Segment Percentages, by Type, 2023 (%)
- Live Vaccine
- Inactivated Vaccine
Global Rinderpest Virus Vaccine Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Doses)
Global Rinderpest Virus Vaccine Market Segment Percentages, by Application, 2023 (%)
Global Rinderpest Virus Vaccine Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Doses)
Global Rinderpest Virus Vaccine Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Rinderpest Virus Vaccine revenues in global market, 2019-2024 (Estimated), ($ millions)
- Key companies Rinderpest Virus Vaccine revenues share in global market, 2023 (%)
- Key companies Rinderpest Virus Vaccine sales in global market, 2019-2024 (Estimated), (K Doses)
- Key companies Rinderpest Virus Vaccine sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Zoetis
- Merck Animal Health
- Hipra
- Boehringer-Ingelheim
- Ceva
- Creative Biolabs
- China Animal Husbandry Industry
- Jinyu Bio-technology
- TECON
- Shenzhen Huaweite Biotechnology
- Beijing Centrebio Biology
- Guangdong Winsun Bio Pharmaceutical
- SPAH
- Wuhan Keqian Biology
Outline of
Major Chapters:
Chapter 1: Introduces the definition of Rinderpest Virus Vaccine, market overview.
Chapter 2: Global Rinderpest Virus Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Rinderpest Virus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Rinderpest Virus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Rinderpest Virus Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
